Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology crawled time : 12:00 save search
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
LNTH | $62.34 1.4% 1.38% 1.3M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
first conference
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
TGTX | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
briumvi neurology sclerosis for meeting therapeutics
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: -5.82%
H: 0.0%
C: 0.0%
first report update financial results
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
ARDX | $6.445 -1.6% -1.63% 3.5M
|
Health Technology
|
| O: -2.82%
H: 0.0%
C: 0.0%
first report financial results
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
MNPR | $0.688 5.04% 4.8% 78K
|
Health Technology
|
| O: 3.55%
H: 0.0%
C: 0.0%
nuclear presentation for meeting imaging molecular
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
BIVI | $0.488 3.52% 3.4% 1.4M
|
Health Technology
|
| O: 6.94%
H: 0.0%
C: 0.0%
ne3107
Windtree Therapeutics Announces Reverse Stock Split
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
WINT | News | $0.3399 -15.3% -18.06% 1.8M
|
Health Technology
|
| O: -30.25%
H: 0.0%
C: 0.0%
therapeutics
Lexicon Pharmaceuticals to Host 2024 Investor Day
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
LXRX | $1.625 0.31% 0.31% 3.7M
|
Health Technology
|
| O: -4.61%
H: 0.0%
C: 0.0%
day pharmaceuticals
Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
IMMP | News | $2.205 -2.43% -2.73% 270K
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
imp761 institute research study
BioLife Solutions Announces the Divestiture of its Stirling Freezer Business
Published: 2024-04-18 (Crawled : 12:00) - prnewswire.com
BLFS S | $15.85 4.69% 4.48% 600K
|
Health Technology
|
| O: -8.9%
H: 0.0%
C: 0.0%
business solutions
BiomX Announces the Appointment of Susan Blum to its Board of Directors
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
PHGE | $0.2937 4.86% 0.1% 110K
|
Health Technology
| Email alert
Add to watchlist
Quebec's INESSS recommends BEYFORTUS for the prevention of RSV for all infants 8 months of age and younger(1)
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.81%
H: 0.0%
C: 0.0%
beyfortus for rsv
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
CALT | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
nephropathy congress world nefecon trial therapeutics
Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
ALDX 4 | $3.99 0.5% 0.5% 430K
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: 0.0%
day research therapeutics development
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
|
| O: 10.02%
H: 0.0%
C: 0.0%
bb-301 first positive biopharma for trial opmd study
Repligen to Report First Quarter 2024 Financial Results
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
RGEN | News | $157.12 -2.4% -2.46% 750K
|
Health Technology
|
| O: 0.24%
H: 2.41%
C: -2.57%
first report financial results
BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
BWAY | News | $4.8 -4.95% -5.21% 80K
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
israel
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
WINT | News | $0.3399 -15.3% -18.06% 1.8M
|
Health Technology
|
| O: -4.17%
H: 0.0%
C: 0.0%
business key therapeutics financial results
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
CLDX | News | $38.49 -2.88% -2.96% 580K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
urticaria study
Royalty Pharma Declares Second Quarter 2024 Dividend
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
RPRX | News | $27.885 1.0% 0.99% 2.1M
|
Health Technology
|
| O: -1.5%
H: 0.84%
C: 0.25%
pharma royalty
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.